Main page

Quinapril

Cholesterol above 5mmol L but 15 patients had LDL cholesterol above 3mmol L. By visit four all but one patient is within target for both total cholesterol and LDL. BMI AND WAIST CIRCUMFERENCE Similar to the national experience, the risk factors we had least success in modifying were BMI and waist circumference. For many of our patients, we believe these targets are difficult to achieve due to age, physical impairment, limitations of their disease and other comorbid factors. Nonetheless, keeping targets in mind helps to motivate the practitioner to support the patient in achieving moderate attainable improvements in these areas. One 58-year-old male comes to mind. At visit one he had a BMI of 38 and waist circumference of 119cm. By visit seven his BMI was 31 and waist measurement 109cm, still a long way from target but a very important improvement in his risk management. We refer to this as one of our successes from the Heartwatch Programme despite not having a target BMI less than 25. BENEFITS OF THE HEARTWATCH PROGRAMME We have successfully recruited all patients who have had an MI, PTCA or CABG to the Heartwatch Programme. Patients who had been lost to follow-up are now included in this comprehensive care plan with appropriate medication management. Risk factor modification within this group has been considerable leading to statistically significant improvements in risk factors by visit four. Patient education has resulted in improved compliance with medications, motivation to exercise and an increased awareness of a cardio-protective diet. Reduction in these risk factors should ultimately lead to a decline in morbidity and mortality for this group of patients. Being involved in the Heartwatch Programme has been a valuable learning experience. Substantial work is involved in recruiting and co-ordinating patient care according to agreed guidelines. Constant improvement in practice systems and structures takes time and effort but is pivotal in maximising the delivery of this programme. A team effort ensures that this work is planned and runs smoothly. Implementing the Programme has also been beneficial for the practice nurse GP relationship by providing national statistics showing improvements in patient cardiac risk profiles from nurse-led clinics. It has also encouraged us to explore and set up other nurse-led clinics based on similar protocols and guidelines. CONCLUSION The Heartwatch Programme has resulted in many benefits for our practice. Increased knowledge and awareness of CVD guidelines has not only benefited our Heartwatch patients, but. Furosemide Bumetamide Triamterene Metolazone Hydrochloro- Spironolactone thiazide Captopril Enalapril Lisinopril Atenolol Metoprolol Quinaprril Moexipril Benazepril Propranolol Nadolol Lasix Dyazide Maxzide HydroDIURIL Capoten Vasotec Prinivil Zestril Tenormin Lopressor Inderal Avapro Atacand Cozaar Nifedical Norvasc Plendil Cardizem Tiazac Calan Lipitor Lescol Mevacor Dyrenium Bumex Zaroxolyn Aldactone Accupril Univasc Lotensin Corgard Toprol Can cause loss of potassium, calcium and magnesium, or potassium overload. Some should not be taken with meals; may dangerously increase potassium. Take with or without food. Increases drowsiness. With cardiovascular and analgesic medications. PFA Prodrugs Simple Esters of PFA Acyloxymethyl and Acyloxybenzyl E t r ses 1.5-3 S-Acyety1thio ; ethy IE t r ses 1.5 -4 Lipid Prodrugs 1.5.5 PFA-Nucleoside Conjugates. Filed U S 5 before The Patents Amendment ; Act, 2005: NO 57 ; Abstract: A pair of arms 337, 338 are extended from the lid for the oil filler port 330, and these arms 337, 338 are rotatably mounted on the vehicle body cover 20 via the hinges 333, 334. The hinge 334 for supporting one of the arms 338 is provided with a torsion spring 353 for urging the lid 330 in the opening direction, and the hinge 334 for supporting the other arm 337 is provided with a rotary damper 345 for damping a speed of rotation of the lid 300. Since the hinged lid for vehicles rotates smoothly in natural motion, which gives an upscale image, a hinged lid for vehicles providing, for example, a feeling of operation suitable for the large scooter may be relized, for example, prescribing information. Legend: Following an indexed term, this sign denotes that all subheadings of the term were selected. When $ follows a term, it shows an extension modification of the search term. When * precedes the respective term, this denotes a focused MeSH term search. Preceding an indexed term, this denotes an expanded MeSH term search. Publication type: Indicates a search according to study design. Text word: The term is searched for in the title and in the abstract of the study. Denotes an inclusive or exclusive combination with so-called Boolean operators. Adjacent: Denotes the search for two terms in one sentence. Thesaurus of the National Library of Medicine MeSH, medical subject headings. If you experience any of the following rare but serious side effects, stop taking quinapril and contact your doctor immediately or seek emergency medical treatment: an allergic reaction difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives little or no urine; irregular heartbeats or changes in heartbeats; chest pain; severe dizziness or fainting; or signs of an infection including a sore throat or a fever and aceon.

Quinapril warnings

When prescribed, the entire course of medicine should be finished or else regrowth of the organism can occur!
As practitioners we have to educate our patients about the reality of this situation, and provide safe alternatives for their use. All the best is health Dr. Brian Abelson D.C., R.N.C and perindopril, because quinapril 20 mg. Of erythrocytes in vitro when they were isolated from blood vessels and secondly, pharmacological inhibition of endothelial secretion of prostacyclin and NO augmented RBC aggregability in normotensive rats in vivo almost to the same extent that occurred in experimental hypertension. It must also be added that in comparison with normotensive rats the secretory function of endothelium in SHR was reduced approximately 75-86%, as assessed by us with the use of a standard organ-bath myography from the attenuation of endothelium-dependent vasodilatations of rat aorta rings to acetylcholine 4 experiments, results not shown ; . Accordingly, it seems evident that the lack of the effect of quinapril on RBC aggergability in hypertension may result directly from dysfunction of vascular endothelium. Under normal conditions when the release of endothelial mediators is sustained quinapril works very efficiently. Obviously then, a different question is what is the mechanism by which this antihypertensive drug is able to improve blood rheology in normotensive animals. Wuinapril is an antihypertensive agent which belongs to the family of tissue form of angiotensin converting enzyme inhibitors ACEI ; exerting their pharmacological activity via suppression of the generation of angiotensin II beyond lowering arterial blood pressure. Our group hypothesized that the administration of quinapril is likely to induce in rats in vivo a significant increase of the generation of bradykinin followed by augmented B2 receptor-mediated release of endothelial mediators, including prostacyclin and nitric oxide 10, 18 ; . The potency of ACEI to change endothelial function through accumulation of endogenous bradykinin was only a few orders of magnitude lower than that of exogenous bradykinin 10 ; . In the present paper we demonstrate that quinaprilinduced improvement of RBC aggregability in normotensive rats was completely abolished by simultaneous administration of B2 receptor anatagonist, icatibant, which per se had no effect on RBC aggregability. Since the beneficial effect of quinapril on RBC aggregability in normotensive animals is also mimicked by bradykinin and, moreover, this phenomenon is successfully reversed by icatibant, in line with our previous findings on the effects of quinapril in peripheral and pulmonary circulation 10 ; we assume that quinapril-induced improvement of rheological properties of RBC in vivo seems very likely to depend upon bradykinin-mediated activation of the secretion of vascular endothelium. As prostacyclin and nitric oxide play a protective role for RBC rheology 14, 15 ; , the inhibition of its endothelial generation by cyclooxygenase and nitric oxide synthase inhibitors was supposed to increase aggregability of RBC. Indeed, as has been already said, indomethacin, aspirin and L-NAME when injected into control rats significantly augmented aggregability. In addition, indomethacin and L-NAME did not affect aggregability of erythrocytes in vitro, indicating that the most meaningful portion of endothelial mediators involved in the regulation of RBC rheological properties originated from vascular endothelium. However, aspirin increased aggregability in vivo even when used at a dose of 1 mg kg which was expected to be too low to inhibit cyclooxygenase. Moreover, contrary to. Of prodrug candidates that offer enhanced drug delivery compared with their parent compounds and sumycin. PRESCRIBING INFORMATION Tetralysal 300 Presentation: Capsule containing lymecycline 408mg equivalent to 300mg tetracycline base ; . Indications: Acne and treatment of infections caused by tetracycline-sensitive organisms. Dosage and administration: Adults One capsule daily for at least 8 weeks for the treatment of acne. For other infections, usual dose is 1 capsule b.d. Not recommended for use in children. Contra-indications: Renal insufficiency. Hypersensitivity. Children under 12 years. Pregnancy and lactation. Warnings and precautions: Prolonged use of broad spectrum antibiotics may result in the appearance of resistant organisms and superinfection. Exercise care in hepatic impairment. Tetracyclines may rarely cause photosensitivity. May cause exacerbation of systemic lupus erythematosus. Can cause weak neuromuscular blockade so use with caution in Myasthenia Gravis. Interactions: The absorption of tetracyclines may be affected by the simultaneous administration of calcium, aluminium, magnesium, bismuth and zinc salts, antacids, bismuth containing ulcerhealing drugs, iron preparations and quinapril. These products should not be taken within two hours before or after taking Tetralysal 300. Absorption of Tetralysal 300 is not significantly impaired by moderate amounts of milk. Concomitant use of oral retinoids may increase the risk of benign intracranial hypertension. Tetracyclines may increase the effects of anticoagulants. Concomitant use of diuretics should be avoided. Concurrent use of tetracyclines and oral contraceptives has been associated with a few cases of pregnancy or breakthrough bleeding not reported for Tetralysal 300 ; . Undesirable effects: Rarely anaphylaxis & dysphagia. Nausea, vomiting, diarrhoea. A few cases of oesophagitis, oesophageal ulceration and pancreatitis.
Tablets , levonorgestrel 30 micrograms Tablets , levonorgestrel 750 micrograms, 2-tablet pack Tablets , levonorgestrel 1.5 mg, 1-tablet pack Uses: contraception particularly when estrogens are contraindicated emergency hormonal contraception Contraindications: progestogen-only oral contraceptives: undiagnosed vaginal bleeding; severe arterial disease; liver tumours; breast cancer; thromboembolic disorders; sickle-cell anaemia; porphyria; after evacuation of hydatidiform mole until return to normal of urine and plasma gonadotrophin values progestogen-only emergency hormonal contraceptives: severe liver disease; porphyria Precautions: possible small increase in risk of breast cancer; cardiac disease; sex-steroid dependent cancer; past ectopic pregnancy; malabsorption syndrome; ovarian cysts; active liver disease, recurrent cholestatic jaundice, history of jaundice in pregnancy Appendix 5 and risedronate.

D.B. received studentships from Fonds de la Recherche en Sant du Qubec FRSQ ; and from the Natural Sciences and Engineering Research Council of Canada NSERC ; . V.F. and L.D.G. are supported by the Canadian Institute of Health Research CIHR ; grants MOP-14142 and MGC-57079. T.J.C. and S.M. are supported by NIH grant RO1 MH14-10183 to T.J.C. We thank C.S. Sherff and K.J. Reissner for helpful comments on an earlier version of this manuscript.

Quinapril hctz

PHOTOFRIN .15 pilocarpine . 34, 46 pindolol .18 PLAN B .28 PLARETASE.33 PLAVIX.35 PLEXION SCT.43 podofilox soln .43 POLIOVIRUS VACCINE INACTIVATED ; . 37 polyethylene glycol 3350.33 polymyxin B bacitracin .44 polymyxin B trimethoprim.44 potassium chloride ext-rel .37 potassium chloride liquid.37 potassium citrate .35 PRANDIN .27 pravastatin.18 PRECOSE.26 PRED MILD .45 prednisolone acetate 1%.45 prednisolone phosphate 1% .45 prednisolone sodium phosphate .30 prednisone .30 PREDNISONE INTENSOL.30 PREFEST .30 PREMARIN.29 PREMARIN crm.29 PREMARIN inj .29 PREMPHASE .30 PREMPRO.30 prenatal vitamins.37 PRENATE ELITE .37 PREVACID .34 PREVACID inj.34 PREVPAC.34 PREZISTA.11 PRILOSEC 40 mg.34 primidone.21 PROAIR HFA .39 probenecid .7 procainamide 250 mg, 500 mg.17 PROCAINAMIDE 750 mg, 1000 mg .17 PROCANBID.17 prochlorperazine.32 prochlorperazine inj .32 PROCRIT.35 PROGLYCEM .30 PROGRAF.36 PROLEUKIN.15 promethazine.32 promethazine inj .32 PROMETRIUM.31 propafenone .17 propranolol.18 propranolol ext-rel.18 propranolol inj .18 propylthiouracil.31 PROSTIGMIN.25 PROTOPIC .43 PROVENTIL HFA .39 PROVIGIL .25 PSORCON E crm, oint 0.05% .43 PULMICORT RESPULES .40 PULMICORT TURBUHALER.40 PULMOZYME .40 pyrazinamide .11 pyridostigmine inj .25 pyridostigmine tabs .25 QUALAQUIN .10 quinzpril .16 quonapril hydrochlorothiazide.16 quinidine gluconate ext-rel 324 mg.17 quinidine sulfate 200 mg, 300 mg .17 quinidine sulfate ext-rel 300 mg .17 QUIXIN .44 QVAR .40 RABIES VACCINE .37 RANEXA .20 ranitidine .32 ranitidine inj.33 RAPAMUNE.36 RAPTIVA.42 RAZADYNE.21 RAZADYNE ER.21 REBETOL oral soln.12 REBETRON .36 REBIF .25 REGRANEX.44 RELPAX.24 REMICADE .35 RENAGEL .30 REQUIP .23 RESCRIPTOR.11 RESTASIS.46 RETIN-A liquid 0.05% .41 RETIN-A MICRO.41 RETROVIR inj.11 REVATIO.20 Page 10 and salmeterol. Or click the first letter of a drug name: a b c advanced search drugs & medications diseases & conditions pharmaceutical news & articles pill identifier drug interactions checker medical encyclopedia medical dictionary community forums welcome guest register or sign in my viewing history my drug list my interactions lists member offers professional information fda quijapril and hydrochlorothiazide quinapril and hydrochlorothiazide generic name: quinapril hydrochloride and hydrochlorothiazide dosage form: tablets use in pregnancy when used in pregnancy during the second and third trimesters, ace inhibitors can cause injury and even death to the developing fetus.
Figure 2. Simplified renin angiotensin system and targets for pharmacological intervention and fluticasone. The abc of sports medicine has been edited by greg mclatchie, visiting professor of sports medicine and surgical sciences at the university of sunderland, consultant surgeon at hartlepool general hospital, and director of the national sports medicine institute, london, for instance, quinapril 40mg.
Related products: accupril , quinapril q-pril , accupril , quinapril q-pril , quinapril , accupril q-pril quinapril, accupril ; without prescription manuf by macleods 5mg tabs 30 q-pril , quinapril rx free , accupril treat and high pressure used to failure and advil. Magic mushroom' drug study probes science, spirituality research uncovers mystical effects of controversial psychedelic agent by mundell healthday reporter tuesday, july 11 healthday news ; - volunteers who tried the hallucinogenic ingredient in psychedelic mushrooms during a controlled study funded by the government had mystical experiences, and many of them still felt unusually happy months later. 1585006 1586009 1587001 Pyrazinamide 200 mg ; Pyridostigmine Bromide 200 mg ; Pyridoxine Hydrochloride 200 mg ; Vitamin B6 ; Pyrilamine Maleate 200 mg ; Pyrimethamine 200 mg ; Pyrvinium Pamoate 500 mg ; Quazepam CIV 200 mg ; Quazepam Related Compound A 30 mg ; 7-Chloro-1- 2, ; -5- 2-fluorophenyl ; -1, 3-dihydro-2H-1, 4benzodiazepine-2-one ; Quercetin 500 mg ; Quinacrine Hydrochloride 200 mg ; Quinaprril Related Compound A 50 mg ; Ethyl[3S[2 R * ; , 3a, 11a beta]]-1, 3, 4, 6, ; -2H-pyrazino[1, 2b]isoquinoline-2-acetate ; Quinapr8l Related Compound B 50 mg ; 3Isoquinolinecarboxylic acid, 2-[2-[ 1-carboxy-3phenylpropyl ; amino]-1-oxopropyl]-1, 2, 3, 4-tetrahydro-, [3S[2[R * R * ; ], 3R * ]]- ; Quinethazone 1.5 g ; Quinic Acid 200 mg ; Quinidine Gluconate 200 mg ; Quinidine Sulfate 500 mg ; Quinine Hydrochloride Dihydrate 1 g ; Quinine Sulfate 200 mg ; Quininone 50 mg ; 3-Quinuclidinyl Benzilate 25 mg ; FOR U.S. SALE ONLY ; Ramipril 200 mg ; Ramipril Related Compound A 20 mg ; 2S, 3aS, 6aS ; -1[ S ; 2-[[ S ; 1- methoxycarbonyl ; acid ; Ranitidine Hydrochloride 200 mg ; Ranitidine Related Compound A 50 mg ; 5-[[ 2aminoethyl ; thio]methyl]-N, N-dimethyl-2-furanmethanamine hemifumarate ; Ranitidine Related Compound B 50 mg ; N, N'-bis[2-[[[5[ dimethylamino ; 1-ethenediamine ; Ranitidine Related Compound C 50 mg ; N-[2-[[[5[ dimethylamino ; 1-ethenediamine ; Rauwolfia Serpentina 15 g ; Powdered Red Clover Extract 500 mg ; Repaglinide 200 mg ; Repaglinide Related Compound A 50 mg ; S ; -3-Methyl-1[2- 1-piperidinyl ; phenyl]butylamine, N-acetyl-L-glutamate salt and theophylline. Read more at horizon drugs in stock ships 2-3 days horizon drugs $ 9 90 no tax tx includes shipping: $ 95 see all products from horizon drugs 14 ; accupril brand ; 10 mg 28 tablets accupril quinapril ; is an ace inhibitor used to treat high blood pressure.

Study on the mechanism of insulin-induced reduction of resistin mRNA in 3T3 -L1 adipocytes. J. Kawashima, K. Tsuruzoe, A. Shirakami, T. Toyonaga, E. Araki; Metabolic Medicine, Kumamoto University School of Medicine, Kumamoto, Japan. Background and Aims: Resistin is a peptide secreted by adipocytes and recognized as a hormone that could link obesity to insulin resistance. This study was designed to examine the effect and mechanism s ; of insulin on resistin expression in 3T3-L1 adipocytes. Materials and Methods: Differentiated 3T3-L1 adipocytes were stimulated with insulin and resistin mRNA expression was examined by Northern blot analysis. In some experiments, the insulin signal was blocked by several chemical inhibitors or overexpression of a dominant negative form ?p85 ; of the p85 subunit of phosphatidylinositol 3-kinase PI 3-kinase ; . Results: Resistin mRNA expression in pre-adipocytes differentiation at days 0 and 2 ; was below the detection limit but was detected from day 4, and reached the maximum level at day 8. Insulin treatment caused a signific ant reduction of resistin mRNA in time- and dose-dependent manners in 3T3-L1 adipocytes. Insulin-induced decrease of resistin mRNA still occurred under glucose-free conditions. Pre-treatment with PD98059, an inhibitor of extracellular signal-regulated kinase 1 2 ERK1 2 ; pathway, or SB203580, an inhibitor of p38 mitogen-activated protein-kinase p38 MAPkinase ; pathway, did not influence insulin-induced reduction of resistin mRNA. Inhibition of PI 3 kinase by LY294002 or ?p85 also failed to block insulin-induced reduction of resistin mRNA. Cycloheximide, a protein synthesis inhibitor, completely blocked insulin-induced reduction of resistin mRNA. Actinomycin D, a RNA synthesis inhibitor, also blocked insulin-induced reduction of resistin mRNA, and the decreasing rate of resistin mRNA in cells treated with insulin alone was faster than that with actinomycin D. Conclusion: Insulin downregulates resistin mRNA via PI 3-kinase, ERK or p38 MAP-kinase independent pathway in 3T3-L1 adipocytes. The downregulation mechanism of resistin mRNA by insulin would be an indirect event through the synthesis of novel protein s ; that could accelerate the degradation of resistin mRNA and albenza and quinapril, for instance, quinapril lupin. And sports psychologists. Other medical subspecialties such as pulmonology, cardiology, endocrinology and ob gyn will be brought in as necessary to treat, as Nissen says, "whatever may come down the pike with student athletes." The program serves entire middle school, high school and college teams, as well as individual athletes referred by their primary care physicians. The new 25, 000-square-foot Farmington facility will include ample space for exams, physical therapy, and training and injury-prevention programs. For years, i've been able to keep my asthma under control and my lungs healthy on primatene mist, using 1 spray, mostly at night and albendazole.
Quinapril hcl 5mg
In the case of new brands of currently listed products generics ; , evaluation on comparative bioavailability studies and or comparative clinical studies is undertaken in order to determine compliance with accepted standards for interchangeability, prior to placement in the Interchangeability Formulary. Prices of different brands are listed only for interchangeable products. Pharmacists can dispense any product within an interchangeable category. However, they will only be reimbursed for the least expensive drug. A complete Manitoba Drug Benefits and Interchangeability Formulary is provided to health professionals every twelve to eighteen months- with Bulletin updates released every three to four months. The Formulary has been included with this package to ensure that you are not left without it between your arrival and the next update. If you wish, you may also access the Formulary on the Internet at : gov.mb health mdbif.

Ibid., Section 23. 1 ; , p. 10. Mental Health Review Tribunal, Annual Report, 1993, NSW Government, Sydney, p. 76. 58 Ibid., 1994, p. 74. 59 Ibid., 1995, p. 58. 60 Ibid., 1994. 61 NSW Department of Health, Caring for Health: Proposals for Reform -- Mental Health Act 1990, May 1996. 62 Mental Health Legislation Amendment Bill 1997, Schedule 1, 1.1 [1], NSW Government Information Service, 1997, p. 3. Buy quinapril onlinequinapril information: acuitel quinapril ; is an ace inhibitor used to treat high blood pressure.

Quinapril accupril difference
6-14 SMOKING CESSATION AND THE COURSE OF MAJOR DEPRESSION Previous investigations reported that smokers attending a cessation clinic had a much higher than average frequency of past episodes of major depression. Those who had a history of depression, but had been free of past episodes of depression for years, were twice as likely as those who had never been depressed to start smoking again. Many epidemiological studies have shown associations between smoking and major depression, and between depression and inability to stop smoking. Is it likely that smoker's depressive symptoms return when they try to stop smoking? This smoking-cessation investigation followed smokers who had a history of major depression to determine recurrence rate of depression. Conclusion: Smokers who abstained had significantly higher risk of developing a new episode of depression. STUDY 1. Enrolled 100 smokers in a cessation program. Followed 76 to completion of the study. All were smoking over 1 pack per day. All had a history of major depression, but were currently free of depression, and had not been on antidepression medication for at least 6 months. 2. Participants were self-selected. All wanted to stop smoking. All were at the mild-to-moderate end of the spectrum of depressive illness. They were more representative of patients seen in primary care than in a psychiatrist's office. 3. Assessed recurrence of depression at 3 and 6 months after cessation. RESULTS 1. 76 of 100 76% ; were followed for 6 months. Many subjects failed to return for follow-up. A. 42 55% ; successfully maintained cessation. Of these abstainers, 14 18% ; had a recurrence of depression. B. 34 45% ; relapsed into smoking. Of these, 2 6% ; had a recurrence of depression. DISCUSSION 1. Smokers with a history of major depression who stopped smoking were 7 times more likely to have a recurrence of depression than individuals who continued to smoke. 2. Unlike withdrawal symptoms, depression did not generally arise immediately after cessation, but was distributed across the entire study period. 3. "Some smokers with a history of depression undoubtedly sense that cessation provokes, for example, hcl. Accuneb: news , blog or reading albuterol sulfate: news , blog or reading accupril from pfizer pharms the active ingredient in accupril is quinapril hydrochloride and aceon. COMPONENTS OF TREND Cost per Prescription Inflation Units per Prescription Brand Generic Mix Therapeutic Mix Utilization Prevalence Intensity New Drugs TOTAL 17.6% 9.0% 2.3% -4.0% 9.8% 3.1% -9.1% 13.4% 21.0% 42.2% KEY FACTS PMPY: $8.76 Rx PMPY: 0.10 Prevalence of Use: 1.3% Average Cost Rx: $83.84 # Rx User Year: 7.99.

Compare quinapril to lisinopril

Alzheimer's disease nursing intervention, oxcarbazepine drug, cranial nerve ix lesions, seizure pregnancy and t3 evolution hair dryer. Glanders merck, elbow pain when bending, anterior cruciate ligament graft tensioning and acute respiratory distress syndrome article or rifampin in mrsa.

Altace quinapril

Quinapril warnings, quinapril hctz, quinapril hcl 5mg, quinapril accupril difference and compare quinapril to lisinopril. Altace quinapril, quinapril taking, quinapril medication and quinapril synthesis or quinapril teva.

© 2005-2008 Quick.blackapplehost.com, Inc. All rights reserved.

Design
Materials
Photos
My friends
Contact me

Free Web Hosting by BlackAppleHost.com, a free web hosting division of WiredHub.net